Latest Europe News

European Lithium and Critical Metals Corp. have amended their merger agreement, introducing a sale facility option for small shareholders and switching to direct share issuance, aiming for scheme implementation in October 2026.

EMC Gold appoints Agne Ahlenius as CEO, reinforcing its strategic pivot to Spain with leadership focused on advancing the Salave Gold Project’s permitting and stakeholder engagement.

Germany’s Hesse State Office has issued new GMP guidance that questions the viability of fragmented medicinal cannabis supply chains, reinforcing ECS Botanics’ integrated manufacturing approach and potentially tightening market supply.

Osmond Resources is advancing its Orión EU Critical Minerals Project with imminent assay results, upcoming resource estimates, and a secondary listing on the Madrid Stock Exchange, aiming to become the EU's first producer of rare earth-bearing minerals.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

OncoSil Medical has submitted its Humanitarian Device Exemption application to the FDA for its OncoSil™ device targeting distal cholangiocarcinoma, entering the final review phase with a decision expected within 45 days.

Talga Group has begun commercial deliveries of its Talnode®-C battery anode to Nyobolt, marking a key revenue milestone and advancing its European supply ambitions. The 3,000-tonne offtake deal sets the stage for Talga's planned commercial-scale anode plant, with further customer negotiations underway.

Cyclopharm Limited delivered a record $17.1 million in revenue for 1H FY26, driven by a 73% surge in US Technegas® sales. However, delays in clinical guideline publication have pushed the short-term US installation target beyond 2026, while medium-term ambitions remain intact.

Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.

OncoSil Medical secures a spot in the PALACROS consortium, advancing its OncoSil™ device through a cost-efficient Phase II trial targeting unresectable locally advanced pancreatic cancer.

Krakatoa Resources has launched its second underground drilling season at the Zopkhito Antimony-Gold Project, aiming to convert a foreign resource estimate into a JORC-compliant Mineral Resource Estimate while pushing early mine development.

Altech Batteries has gained a three-month extension to secure full financial close on its €46.7 million German government grant, supporting its innovative CERENERGY® Sodium Chloride Solid State battery project in Saxony.